558 related articles for article (PubMed ID: 23295915)
1. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans.
Okuno K; Takashima K; Kanai K; Ohashi M; Hyuga R; Sugihara H; Kuwamoto S; Kato M; Sano H; Sairenji T; Kanzaki S; Hayashi K
J Med Virol; 2010 May; 82(6):977-86. PubMed ID: 20419811
[TBL] [Abstract][Full Text] [Related]
3. Healthy rabbits are susceptible to Epstein-Barr virus infection and infected cells proliferate in immunosuppressed animals.
Khan G; Ahmed W; Philip PS; Ali MH; Adem A
Virol J; 2015 Feb; 12():28. PubMed ID: 25851649
[TBL] [Abstract][Full Text] [Related]
4. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
5. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
[TBL] [Abstract][Full Text] [Related]
6. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Epstein-Barr virus infection in a human signet ring cell gastric carcinoma cell line, HSC-39.
Luo B; Murakami M; Fukuda M; Fujioka A; Yanagihara K; Sairenji T
Microbes Infect; 2004 Apr; 6(5):429-39. PubMed ID: 15109957
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (HHV-4) inoculation to rabbits by intranasal and oral routes results in subacute and/or persistent infection dissimilar to human disease.
Rajčáni J; Szenthe K; Durmanová V; Tóth A; Asványi B; Pitlik E; Stipkovits L; Szathmary S
Intervirology; 2014; 57(5):254-69. PubMed ID: 24993954
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
Swaminathan S; Tomkinson B; Kieff E
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1546-50. PubMed ID: 1847527
[TBL] [Abstract][Full Text] [Related]
11. In vitro Epstein-Barr virus infection model of rabbit lymphocytes from peripheral blood or spleen.
Kanai K; Kato K; Sano H; Nagata K; Okuno K; Kuwamoto S; Higaki H; Sugihara H; Kato M; Murakami I; Hayashi K
Intervirology; 2011; 54(1):17-24. PubMed ID: 20689312
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen JI; Wang F; Mannick J; Kieff E
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
[TBL] [Abstract][Full Text] [Related]
13. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
[TBL] [Abstract][Full Text] [Related]
15. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection in sarcomatoid renal cell carcinoma tissues.
Kim KH; Han EM; Lee ES; Park HS; Kim I; Kim YS
BJU Int; 2005 Sep; 96(4):547-52. PubMed ID: 16104908
[TBL] [Abstract][Full Text] [Related]
20. Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults.
Palma I; Sánchez AE; Jiménez-Hernández E; Alvarez-Rodríguez F; Nava-Frias M; Valencia-Mayoral P; Salinas-Lara C; Velazquez-Guadarrama N; Portilla-Aguilar J; Pena RY; Ramos-Salazar P; Contreras A; Alfaro A; Espinosa AM; Nájera N; Gutierrez G; Mejia-Arangure JM; Arellano-Galindo J
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):266-72. PubMed ID: 23276887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
